Met Life Investment Management, LLC Syros Pharmaceuticals, Inc. Transaction History

Met Life Investment Management, LLC

  • $16.6 Billion
  • Q2 2024

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022
SELL
$3.26 - $4.66 $70,732 - $101,108
-21,697 Closed
0 $0
Q3 2021

May 17, 2024
BUY
$4.08 - $5.66 $15,687 - $21,762
3,845 Added 21.54%
21,697 $96,000
Q3 2021

Jun 21, 2023
BUY
$4.08 - $5.66 $88,523 - $122,805
21,697 New
21,697 $96,000
Q3 2021

Mar 22, 2023
BUY
$4.08 - $5.66 $15,687 - $21,762
3,845 Added 21.54%
21,697 $96,000
Q3 2021

Nov 15, 2021
BUY
$4.08 - $5.66 $88,523 - $122,805
21,697 New
21,697 $97,000
Q2 2021

Aug 16, 2021
SELL
$5.01 - $7.48 $89,438 - $133,532
-17,852 Closed
0 $0
Q1 2021

May 17, 2024
BUY
$7.19 - $14.95 $128,355 - $266,887
17,852 New
17,852 $133,000
Q1 2021

Jun 26, 2023
BUY
$7.19 - $14.95 $128,355 - $266,887
17,852 New
17,852 $134 Million
Q1 2021

Mar 22, 2023
BUY
$7.19 - $14.95 $4,055 - $8,431
564 Added 3.26%
17,852 $133,000
Q1 2021

May 14, 2021
BUY
$7.19 - $14.95 $4,055 - $8,431
564 Added 3.26%
17,852 $134,000
Q4 2020

Jun 22, 2023
BUY
$6.66 - $14.66 $115,138 - $253,442
17,288 New
17,288 $187,000
Q3 2020

Jun 26, 2023
BUY
$8.69 - $14.47 $150,232 - $250,157
17,288 New
17,288 $152,000
Q2 2020

May 24, 2024
BUY
$5.21 - $11.03 $90,070 - $190,686
17,288 New
17,288 $184 Million
Q2 2020

Jun 26, 2023
BUY
$5.21 - $11.03 $90,070 - $190,686
17,288 New
17,288 $184,000
Q1 2020

Jul 12, 2023
BUY
$4.46 - $9.2 $77,104 - $159,049
17,288 New
17,288 $102,000
Q1 2020

Mar 22, 2023
SELL
$4.46 - $9.2 $4,821 - $9,945
-1,081 Reduced 5.88%
17,288 $102,000
Q1 2020

May 15, 2020
BUY
$4.46 - $9.2 $77,104 - $159,049
17,288 New
17,288 $103,000
Q4 2019

Feb 14, 2020
SELL
$4.52 - $10.1 $83,027 - $185,526
-18,369 Closed
0 $0
Q3 2019

Jul 12, 2023
BUY
$7.14 - $11.65 $131,154 - $213,998
18,369 New
18,369 $190,000
Q3 2019

Mar 22, 2023
SELL
$7.14 - $11.65 $14,058 - $22,938
-1,969 Reduced 9.68%
18,369 $190,000
Q3 2019

Nov 14, 2019
BUY
$7.14 - $11.65 $131,154 - $213,998
18,369 New
18,369 $191,000
Q2 2019

Jul 12, 2023
BUY
$5.5 - $9.75 $101,029 - $179,097
18,369 New
18,369 $170 Million
Q4 2018

Feb 14, 2019
SELL
$5.55 - $11.34 $112,875 - $230,632
-20,338 Closed
0 $0
Q3 2018

Jul 13, 2023
BUY
$9.74 - $12.92 $127,671 - $169,355
13,108 New
13,108 $156,000
Q3 2018

Mar 22, 2023
BUY
$9.74 - $12.92 $198,092 - $262,766
20,338 New
20,338 $242,000
Q3 2018

Nov 14, 2018
BUY
$9.74 - $12.92 $70,420 - $93,411
7,230 Added 55.16%
20,338 $242,000
Q2 2018

Aug 15, 2018
BUY
$10.16 - $13.65 $133,177 - $178,924
13,108 New
13,108 $134,000

About Syros Pharmaceuticals, Inc.

SYRS Quotes by TradingView
  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $43.1M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email